inPractice® - Timing of Antiretroviral Therapy

Management of IRIS

Authors: Irini Sereti, MD, MHS; Philip Grant, MD (More Info)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 4/1/16 (What's New)

Summary

Guidelines from CDC (Management Guidelines)^{[CDC OI]} and BHIVA (Management Guidelines)^{[BHIVA ART]} support the early initiation of ART in patients with acute OIs (other than cryptococcus), despite the possible risk of IRIS

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Cryptococcus, IRIS, Resource-Limited Settings, Tuberculosis